RankingsPricing
  1. US-listed companies
  2. STERIS plc
  3. Financials
  4. Research & development

STERIS plcSTE

Market cap
$25.9B
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Mar 31, 2025108+3.83%
Mar 31, 2024104+2.07%
Mar 31, 2023102+15.51%
Mar 31, 202288+32.59%
Mar 31, 202166+1.19%
Mar 31, 202066+3.98%
Mar 31, 201963

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)